Dr. Thara Rani R. Damodaran, MD

Dr. Damodaran practices at Mercy Hospital Oklahoma City in Oklahoma City, Oklahoma, part of Mercy.

Dr. Damodaran's NPI, 1265455604, was assigned on July 26, 2006. Dr. Damodaran holds Oklahoma license 31085.

Dr. Damodaran's primary practice is Mercy Hospital Oklahoma City, at 4300 West Memorial Road, Oklahoma City, OK 73120 in Oklahoma County. The practice phone is (405) 755-1515.

Dr. Damodaran's primary practice is Mercy Hospital Oklahoma City in Oklahoma City, Oklahoma, part of Mercy. Dr. Damodaran is also affiliated with Oklahoma Heart Hospital North. The medical group on file is Mercy Clinic Oklahoma Communities. Dmand AI also links Dr. Damodaran to 6 more hospitals, 8 medical groups, 3 home health agencies and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Damodaran practices, 12 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Damodaran's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dmand AI has Dr. Damodaran's licenses on file in 2 states: Oklahoma and Arizona.

CMS data shows 652 Medicare services from Dr. Damodaran across 4 procedure codes in 2024, for 292 Medicare patients. Medicare paid $52,094 for them.

CMS counts 292 Medicare patients who saw Dr. Damodaran in 2024. The largest group is 65 to 74, with 103 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 2.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Damodaran's median patient age at 66, with 40% women.

In 2024, Dr. Damodaran wrote 521 Medicare Part D claims for 95 patients. 98% of them were for generic drugs. CMS names the drug for 483 of them, across 14 drugs with 11 or more claims each, at $144,339 in total drug cost. In 2023, CMS named 299 claims across 14 drugs.

Dr. Damodaran accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Damodaran as offering telehealth.

CMS Open Payments shows 14 general payments to Dr. Damodaran from 7 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 86% of the total. Merck Sharp & Dohme Corporation paid the most, $145.